Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Antibody Persistence and Booster Kinetics in Children
NCT00258856Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Mar 2007
- Countries
- 1
01
Overview
Phase 2, open-label trial of meningococcal A conjugate vaccine in meningococcal meningitis and meningococcal infection (4 arms), sponsored by Sanofi. Primary endpoint: Percentage of Participants With Serum Bactericidal Activity of ≥ 1:8 at 14 days. Started Jan 2006; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitismeningococcal infection
Beyond the preview
Go deeper on NCT00258856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258856.